Puma Biotechnology, Inc.

PBYI ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item Jun 2016 Mar 2016 Dec 2015 Sep 2015 Jun 2015 Mar 2015 Dec 2014 Sep 2014
Assets
Cash & Equivalents $57.8M $78.2M $31.6M $23.6M $59.8M $155.5M $38.5M $28.3M
Accounts Receivable $1.2M — — — — — — —
Inventory — — — — — — — —
Total Current Assets $153.7M $189.4M $223.5M $254.7M $287.8M $316.7M $149.4M $160.1M
Property, Plant & Equipment $5.2M $2.2M $2.4M $2.5M $2.6M $2.4M $2.2M $1.9M
Goodwill — — — — — — — —
Intangible Assets (Excl. Goodwill) — — — — — — — —
Total Assets $170.9M $205.2M $239.8M $271.6M $302.4M $331.9M $162.8M $172.1M
Liabilities
Accounts Payable $24.6M $24.8M $17.8M $9.8M $10.4M $12.6M $15.0M $18.4M
Total Current Liabilities $39.0M $38.9M $32.4M $25.3M $26.1M $26.1M $44.4M $29.4M
Long-Term Debt — — — — — — — —
Total Liabilities $43.8M $40.2M $33.8M $26.8M $27.6M $27.5M $45.7M $30.5M
Stockholders' Equity
Retained Earnings $-658.1M $-591.5M $-520.5M $-458.8M $-398.4M $-333.7M $-281.2M —
Total Stockholders' Equity $127.1M $164.9M $206.0M $244.8M $274.8M $304.3M $117.0M $141.6M
← Newer Page 6 of 8 Older →